Wenwen Ding Source Confirmed

OverviewAI-generated summary

Wenwen Ding's research investigates the intricate connections between the gut microbiota, systemic immunity, and various health conditions. Her work explores the potential of targeting mitochondrial biogenesis and modulating autophagy for the treatment of insulin resistance and type 2 diabetes mellitus. Ding has also examined the role of gut microbiota-driven neuroinflammation in Alzheimer's disease and the potential of harnessing the human gut microbiota to combat multidrug-resistant bacteria.

Further research by Ding has focused on alterations in gut microbiota and systemic immunity in patients with schizophrenia comorbid with metabolic syndrome. She has also studied the relationship between fecal microbiota composition, cytokine expression profiles, and adolescent depression. Her publications cover advances in human organoid development and applications, as well as the inhibitory effects of trimetazidine on liver fibrosis. Ding's scholarly contributions are reflected in her h-index of 8, with 37 total publications and 184 total citations.

Metrics

• h-index: 8
• Publications: 37
• Citations: 342